Related Experiment Videos
Potentiation of carbon tetrachloride-induced hepatotoxicity by 1,3-butanediol
Toxicology and Applied Pharmacology
|January 1, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Do Patient Assessments of Hospital Quality Correlate With Kidney Transplantation Surgical Outcomes?
Transplantation proceedings·2016
Rapid Resolution of Donor-Derived Glomerular Fibrin Thrombi After Deceased Donor Kidney Transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Challenges to research and innovation to optimize deceased donor organ quality and quantity.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation.
Transplantation proceedings·2013
Domino liver transplantation in maple syrup urine disease: a case report and review of the literature.
Transplantation proceedings·2012
10-gingerol potentiates paclitaxel efficacy in triple-negative breast cancer by remodeling gut microbiota and suppressing PI3K/AKT/mTOR signaling pathway.
Toxicology and applied pharmacology·2026
Development of an in vitro chemical hazard screening method using human iPSCs with and without metabolic activation and application to chlorinated paraffins.
Toxicology and applied pharmacology·2026
The impacts of polystyrene nanoplastics on colorectal cancer: Evidence from integrated network toxicity and in vitro approaches.
Toxicology and applied pharmacology·2026
Morin mitigates doxorubicin-induced cardiotoxicity via suppression of oxidative stress, inflammation, and structural remodeling.
Toxicology and applied pharmacology·2026
Raloxifene suppresses chemically-induced oxidative hepatocyte injury in vitro and in vivo by targeting protein disulfide isomerase.
Toxicology and applied pharmacology·2026
METTL3-mediated m6A modification of PARP2 accelerates hepatocellular carcinoma progression.
Toxicology and applied pharmacology·2026